Skip to main content

Table 5 sTNFR-II and IL-8 levels in PNALT and HCC cases

From: Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4

Cytokines (pg/ml) PNALT, N = 17 HCC, N = 30 p-value
sTNFR-II ≥ 398 2 (11.8%) 22 (73%) 0.000
sTNFR-II < 398 15 (88.2%) 6 (27%) 0.000
IL-8 < 345 4 (23.5%) 29 (97%) 0.000
IL-8 ≥ 345 13 (76.5%) 1 (3.3%) 0.000
TNFR-II ≥ 398 or IL-8 <290. Either + ve 5 (29.4%) 30 (100%) 0.000
TNFR-II ≥ 398 and IL-8 <290. Both - ve 12 (70.6%) 0 (0%) 0.000
TNFR-II ≥ 398 and IL-8 <290. Both + ve 0 (0%) 21 (70%) 0.000
Others 17 (100%) 9 (30%) 0.000
  1. PNALT: chronic hepatitis C with persistent normal alanine aminotrasferase; HCC: hepatocellular carcinoma.